Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Hydralazine in Severe Systolic Heart Failure with Mitral Regurgitation
NCT04217135Phase 4Unknown
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Jan 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydralazine in mitral regurgitation (MR), sponsored by Kaohsiung Veterans General Hospital. Status: unknown.
02
Drugs
hydralazine
03
Conditions
mitral regurgitation (MR)
Beyond the preview
Go deeper on NCT04217135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217135.